1,721,019 research outputs found

    Modulation of cytochrome c-mediated extramitochondrial NADH oxidation by contact site density

    No full text
    Data presented in previous reports suggest that in rat liver mitochondria a “bi-trans-membrane” electron transport pathway is present which promotes the transfer of reducing equivalents directly from cytosolic NADH to molecular oxygen inside the mitochondria. Here we show that the oxidation of external NADH is stimulated by atractylate 1 ADP and greatly inhibited by glycerol. These two conditions have been documented to promote the increase and the decrease respectively of the frequency of “contact sites” between the two mitochondrial membranes. NADH oxidation is not affected at all by glycerol and atractylate 1 ADP when TMPD and endogenous cytochrome c are utilized as electron carriers. The results obtained are consistent with the proposal that the bi-transmembrane electron transport chain might be localized at the level of respiratory contact sites having the function of promoting the oxidation of the surplus amount of cytosolic NADH. This electron transport pathway has been suggested to play a decisive role in the early stages of apoptosi

    Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells RID A-8169-2012

    No full text
    Hepatocellular carcinoma (HCC) treatment is challenging because the mechanisms underlying tumor progression are still largely unknown. Transforming growth factor (TGF)-beta 1 is considered a crucial molecule in HCC tumorigenesis because increased levels of patients' serum and urine are associated with disease progression. The aim of the present study was to investigate the inhibition of TGF-beta signaling and its impact on HCC progression. Human HCC cell lines were treated with a TGF-beta receptor kinase inhibitor (LY2109761) whose selectivity was determined in a kinase assay. Exogenous TGF-beta 1 phosphorylates the TGF-beta receptor, consequently activating Smad-2, whereas the drug selectively blocks this effect and dephosphorylates autocrine p-Smad-2 at concentrations ranging from 0.001 to 0.1 mu M. A cytotoxic effect documented by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), trypan blue, and propidium iodide staining assays was observed at 10 mu M, whereas the drug inhibits (P < 0.001) the migration of HCC cells on fibronectin, laminin-5, and vitronectin and invasion through Matrigel (P < 0.001) at concentrations up to 0.1 mu M. LY2109761 up-regulates (P < 0.001) E-cadherin mRNA and protein levels. This increase was localized at the cellular membrane where E-cadherin mediates anchorage that is cell-cell dependent. Consistently, a functional monoclonal antibody that inhibits E-cadherin-dependent cell-cell contact restores the migratory and invasive activity. Finally, nonmetastatic HCC tissues from 7 patients were cultured with TGF-beta 1 in the presence or absence of LY2109761. E-cadherin expression was reduced by TGF-beta 1 and was significantly (P < 0.0001) increased by LY2109761 treatment, measured by quantitative real-time PCR on microdissected tissues and by immunohistochemistry on serial sections. In 72 patients, E-cadherin tissue expression was more weakly expressed in metastatic than in nonmetastatic HCC (P < 0.0001). Conclusion: LY2109761 blocks migration and invasion of HCC cells by upregulating E-cadherin, suggesting that there could be a mechanistic use for this molecule in clinical trials

    Inhibition by butylmalonate of proton influx in nonphosphorylating mitochondria

    No full text
    The impermeability of the inner membrane to protons is one of the four postulates of the chemiosmotic theory on the coupling mechanism between respiration and phosphorylation in mitochondria. However, oxygen uptake in isolated nonphosphorylating mitochondria requires that protons translocated from inside to outside must be, at least in part, retaken up. The nonohmic relationship between the respiration rate and the protonmotive force has been mainly ascribed to an increase in the proton conductance of the inner membrane (proton leak). In liver mitochondria oxygen pulse experiments the rate of both the efflux and the reentry of protons, linked to the oxygen consumption supported by succinate oxidation, is greatly stimulated by low concentrations of butylmalonate. The steady-state level of protons exported outside in the acidification-alkalinization cycle of the medium, generated by an oxygen pulse, is also increased but the rate of oxygen uptake is unaffected. However, in valinomycin-stimulated respiration butylmalonate inhibits the ratio of proton influx/oxygen consumption by 50% and also stimulates the ratio of proton efflux/oxygen consumption by 50%. Titration of the butylmalonate effect gives a saturation curve with a half-maximal effect at 5 microM. Identical results are obtained inthe presence of oligomycin which excludes the involvement of the ATP-synthase complex. The data obtained are not in contrast with the existence in the inner membrane of a channel-like system inhibited by butylmalonate and involved, together with other systems, in promoting the backflow of protons in nonphosphorylating state 4 respiration. Such a system, similar to thermogenin, could be involved in tissues, other than adipose, in a more general thermogenesis program by promoting the dissipation as heat of the energy given by the electrochemical proton gradient. The possibility that butylmalonate might inhibit the proton movement associated with cation and anion transport in mitochondria has also been considered
    corecore